Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 93 entries
View as:

Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT01039220 Org: User:
Start: 12/31/09 End: 11/30/10 Due: 11/30/11

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial

Phase: N/A Priority: Normal
NCT ID: NCT00936195 Org: User:
Start: 01/31/10 End: 06/30/13 Due: 06/30/14

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

Phase: N/A Priority: Normal
NCT ID: NCT00226434 Org: User:
Start: 01/31/06 End: 05/31/10 Due: 05/31/11

Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01463956 Org: User:
Start: 01/06/12 End: 01/22/15 Due: 01/22/16

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Phase: N/A Priority: Normal
NCT ID: NCT00158405 Org: User:
Start: 12/31/02 End: 12/31/06 Due: 12/31/07

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

Phase: N/A Priority: Normal
NCT ID: NCT00113282 Org: User:
Start: 06/30/04 End: 02/29/08 Due: 02/28/09

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Phase: N/A Priority: Normal
NCT ID: NCT00460382 Org: User:
Start: 05/31/07 End: 09/30/09 Due: 09/30/10

Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00121121 Org: User:
Start: 07/31/04 End: 12/31/05 Due: 12/31/06

Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

Phase: N/A Priority: Normal
NCT ID: NCT00122590 Org: User:
Start: 07/31/02 End: 03/31/05 Due: 03/31/06

The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.

Phase: N/A Priority: Normal
NCT ID: NCT01426243 Org: User:
Start: 07/31/11 End: 12/31/17 Due: 12/31/18

Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00122564 Org: User:
Start: 06/30/03 End: 04/30/05 Due: 04/30/06

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Phase: N/A Priority: Normal
NCT ID: NCT00651066 Org: User:
Start: 06/30/10 End: 09/30/12 Due: 09/30/13

Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)

Phase: N/A Priority: Normal
NCT ID: NCT01164462 Org: User:
Start: 03/31/10 End: 04/30/11 Due: 04/30/12

Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)

Phase: N/A Priority: Normal
NCT ID: NCT00120796 Org: User:
Start: 08/31/05 End: 07/31/08 Due: 07/31/09

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

Phase: N/A Priority: Normal
NCT ID: NCT00120367 Org: User:
Start: 04/30/05 End: 12/31/07 Due: 12/31/08

Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM

Phase: N/A Priority: Normal
NCT ID: NCT03661203 Org: User:
Start: 09/30/20 End: 03/31/22 Due: 03/31/23

Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection

Phase: N/A Priority: Normal
NCT ID: NCT00158535 Org: User:
Start: 06/30/02 End: - Due: -

MAKASI Intervention for African and Caribbean Migrants' Empowerment in Sexual Health in Paris Greater Area

Phase: N/A Priority: Normal
NCT ID: NCT04468724 Org: User:
Start: 02/01/19 End: 01/31/21 Due: 01/31/22

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding

Phase: N/A Priority: Normal
NCT ID: NCT00640263 Org: User:
Start: 12/31/09 End: 02/28/14 Due: 02/28/15

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Phase: N/A Priority: Normal
NCT ID: NCT00122525 Org: User:
Start: 07/31/02 End: 07/31/05 Due: 07/31/06

Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)

Phase: N/A Priority: Normal
NCT ID: NCT00623051 Org: User:
Start: 01/31/08 End: 12/31/12 Due: 12/31/13

Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)

Phase: N/A Priority: Normal
NCT ID: NCT00158522 Org: User:
Start: 02/28/03 End: 12/31/07 Due: 12/31/08

Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00119119 Org: User:
Start: 02/28/02 End: 12/31/06 Due: 12/31/07

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00126243 Org: User:
Start: 01/31/99 End: 10/31/03 Due: 10/31/04

Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

Phase: N/A Priority: Normal
NCT ID: NCT01008813 Org: User:
Start: 10/31/09 End: 12/31/10 Due: 12/31/11